Journal
MEDICAL ONCOLOGY
Volume 38, Issue 8, Pages -Publisher
HUMANA PRESS INC
DOI: 10.1007/s12032-021-01540-8
Keywords
COVID-19; SARS-CoV-2; COVID-19 vaccines; Cancer patients; Anticancer treatment
Categories
Ask authors/readers for more resources
With the global emergence of the second wave of COVID-19 infections, vaccination has become crucial. Vaccines have shown to reduce severe illness risk, while cancer patients face added vulnerability to the infection. However, doubts and misconceptions about vaccination during cancer treatment exist.
With the emergence of second wave of COVID-19 infection globally, particularly in India in March-April 2021, protection by massive vaccination drive has become the need of the hour. Vaccines have been proved to reduce the risk of developing severe illness and are emerging as vital tools in the battle against COVID-19. As per the GLOBOCAN database, nearly 19.3 million new cancer cases have been reported in 2020 globally, which posed a significant challenge to health care providers to protect such large number of 'vulnerable' patients from COVID-19. Nevertheless, a considerable degree of doubt, hesitancy and misconceptions are noted regarding the administration of vaccines particularly during active immuno-suppressant treatment. This review article highlights the added vulnerability of cancer patients to the COVID-19 infection and has explored the immunological challenges associated with malignancy, anticancer treatment and COVID-19 vaccination.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available